Showing results (791-800 of 840) with videos related to
Sort By:
Pageof 84
Cancers|October 14, 2022
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver FunctionHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.Hepatology (Baltimore, Md.)|January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinomaShuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.JTO Clinical and Research Reports|October 27, 2025
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLCKensuke Kanaoka, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.Plos One|February 7, 2023
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinomaKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.Nature|July 12, 2023
Mast cells link immune sensing to antigen-avoidance behaviourThomas Plum, Rebecca Binzberger, Robin Thiele, et al.Journal for Immunotherapy of Cancer|April 9, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabYu Sato, Takahiro Kodama, Kazuki Maesaka, et al.Anesthesia and Analgesia|December 29, 2017
Clinical Utility of Intraoperative Motor-Evoked Potential Monitoring to Prevent Postoperative Spinal Cord Injury in Thoracic and Thoracoabdominal Aneurysm Repair: An Audit of the Japanese Association of Spinal Cord Protection in Aortic Surgery DatabaseKenji Yoshitani, Kenichi Masui, Masahiko Kawaguchi, et al.Hepatology (Baltimore, Md.)|May 14, 2022
Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinomaHiroki Murai, Takahiro Kodama, Kazuki Maesaka, et al.Science Translational Medicine|April 19, 2013
A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivoYoriko Saito, Hitomi Yuki, Mitsuo Kuratani, et al.Nature Immunology|April 30, 2013
Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axisYoshitaka Taketomi, Noriko Ueno, Takumi Kojima, et al.Pageof 84